Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid cancer management

K J Hardy1, B R Walker, R S Lindsay

  • 1Department of Endocrine and Metabolic Diseases, Western General Hospital, Edinburgh, UK.

Clinical Endocrinology
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contribution of local regeneration of glucocorticoids to tissue steroid pools.

The Journal of endocrinology·2023
Same author

Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.

Biochemical pharmacology·2017
Same author

Inhibition or deletion of 11β-HSD1 does not increase angiogenesis in ischemic retinopathy.

Diabetes & metabolism·2017
Same author

Forebrain-Specific Transgene Rescue of 11β-HSD1 Associates with Impaired Spatial Memory and Reduced Hippocampal Brain-Derived Neurotrophic Factor mRNA Levels in Aged 11β-HSD1 Deficient Mice.

Journal of neuroendocrinology·2016
Same author

Clinical research: developing an appropriate career structure.

The Veterinary record·2015
Same author

Decreased Npas4 and Arc mRNA Levels in the Hippocampus of Aged Memory-Impaired Wild-Type But Not Memory Preserved 11β-HSD1 Deficient Mice.

Journal of neuroendocrinology·2015

This audit of thyroid cancer management found significant inconsistencies in diagnosis and treatment, including a high false negative rate for fine needle aspiration (FNA) and issues with radioiodine (131I) administration. Developing local guidelines is recommended to improve patient care.

Area of Science:

  • Endocrinology
  • Oncology
  • Nuclear Medicine

Background:

  • Thyroid cancer is the most common endocrine malignancy, with management protocols often debated.
  • Standard management may involve fine needle aspiration (FNA), thyroidectomy, radioiodine (131I) therapy, and TSH suppression.
  • Follow-up typically includes 131I scans and thyroglobulin (Tg) measurements, with 131I administration conditional on TSH levels > 30 mIU/I.

Purpose of the Study:

  • To audit current clinical practices for thyroid cancer management in a large teaching hospital.
  • To identify variations and shortcomings in the diagnostic and therapeutic pathways.
  • To determine the need for local management guidelines.

Main Methods:

  • A retrospective case-note audit was conducted.

Related Experiment Videos

  • The study reviewed 46 patients diagnosed with thyroid cancer between 1988 and 1993.
  • Data on diagnosis, treatment, and follow-up protocols were analyzed.

    • Main Results:

    • The fine needle aspiration (FNA) false negative rate was high at 13%, with non-standardized techniques and reporting.
    • 11% of patients received radioiodine (131I) despite suboptimal TSH levels due to poor control mechanisms.
    • 25% of patients had inadequate TSH suppression due to poor interspecialty communication.
    • 11% underwent scanning with TSH levels below the recommended threshold, and 18% had incomplete thyroglobulin (Tg) monitoring.

    Conclusions:

    • Significant shortcomings were identified in thyroid cancer management, indicating a lack of uniformity even within a single institution.
    • Poor interdisciplinary communication was a notable issue.
    • Implementing a locally agreed-upon protocol is essential to standardize care and improve outcomes for thyroid cancer patients.